Eupraxia Pharmaceuticals (EPRX) Debt Ratio (2022 - 2024)

Eupraxia Pharmaceuticals (EPRX) has reported Debt Ratio for 3 consecutive years, with 0.0 the latest figure, recorded in Q2 2024.

• In Q2 2024, Debt Ratio changed N/A year-over-year to 0.0; the TTM figure through Jun 2024 stood at 0.0 (changed N/A YoY), while the FY2023 annual figure was 0.51, up 6803.49% from the prior year.
• Debt Ratio slipped to 0.0 in Q2 2024 per EPRX's latest filing, from 0.0 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.51 in Q4 2023 and bottomed at 0.0 in Q2 2024.
• Historically, Debt Ratio has averaged 0.13 across 3 years, with a median of 0.0 in 2022.
• On a YoY basis, Debt Ratio climbed as much as 6803.49% in 2023 and fell as far as 6803.49% in 2023.
• Eupraxia Pharmaceuticals' Debt Ratio stood at 0.01 in 2022, then jumped by 6803.49% to 0.51 in 2023, then sank by 99.83% to 0.0 in 2024.
• Business Quant data shows EPRX's Debt Ratio at 0.0 in Q2 2024, 0.0 in Q1 2024, and 0.51 in Q4 2023.